Nigerian tycoon Fidelis Ayebae gains $1.4 million from investment in Fidson
The recent gains solidify Ayebae’s position as one of Africa’s pharmaceutical industry magnates.
Skip to content
The recent gains solidify Ayebae’s position as one of Africa’s pharmaceutical industry magnates.
Ayebae owns an impressive 33.1-percent stake in Fidson Healthcare.
Under Ayebae’s guidance, Fidson Healthcare has achieved exceptional financial growth, reporting a significant increase in profits for the 2022 fiscal year.
Fidson Healthcare has established itself as a leading player in the Nigerian and West African pharmaceutical industries.